Skip to content

Zevra Therapeutics, Inc.: filings

Every Zevra Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 46 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-05fiscal Q2 2026431200001434647-26-000068
10-Q2026-05-06fiscal Q1 202642850001434647-26-000031
10-K2026-03-09fiscal FY 202548980001434647-26-000011
10-Q2025-11-05fiscal Q3 2025431240001434647-25-000011
10-Q2025-08-12fiscal Q2 2025421170001628280-25-039967
10-Q2025-05-13fiscal Q1 202540820001437749-25-016523
10-K2025-03-12fiscal FY 202446940001437749-25-007320
10-Q2024-11-13fiscal Q3 2024401150001437749-24-034916
10-Q2024-08-14fiscal Q2 2024401090001437749-24-026474
10-Q2024-05-09fiscal Q1 202440810001437749-24-015705
10-K2024-04-01fiscal FY 202347980001437749-24-010430
10-Q2023-11-07fiscal Q3 2023381110001437749-23-030690
10-Q2023-08-14fiscal Q2 2023381060001437749-23-023716
10-Q2023-05-15fiscal Q1 202337760001437749-23-014683
10-K2023-03-07fiscal FY 202242850001437749-23-005703
10-Q2022-11-10fiscal Q3 2022371100001437749-22-026683
10-Q2022-08-12fiscal Q2 202235990001437749-22-020394
10-Q2022-05-12fiscal Q1 202234700001437749-22-012182
10-K2022-03-31fiscal FY 202141840001437749-22-007725
10-Q2021-11-10fiscal Q3 2021351080001437749-21-026201
10-Q2021-08-13fiscal Q2 2021351030001437749-21-019912
10-Q2021-05-14fiscal Q1 202132640001437749-21-012167
10-K2021-03-12fiscal FY 202036740001437749-21-005785
10-Q2020-10-30fiscal Q3 2020361070001437749-20-022028
10-Q2020-08-12fiscal Q2 2020361010001437749-20-017682
10-Q2020-05-13fiscal Q1 202031630001437749-20-010603
10-K2020-02-28fiscal FY 201937720001437749-20-003965
10-Q2019-11-14fiscal Q3 2019371040001437749-19-022963
10-Q2019-08-13fiscal Q2 2019361000001437749-19-016596
10-Q2019-05-14fiscal Q1 201931600001437749-19-009870
10-K2019-03-01fiscal FY 201834680001437749-19-003789
10-Q2018-11-09fiscal Q3 201830790001437749-18-020328
10-Q2018-08-10fiscal Q2 201835950001437749-18-015224
10-Q2018-05-11fiscal Q1 201830610001437749-18-009627
10-K2018-03-30fiscal FY 2017361740001437749-18-005932
10-Q2017-11-09fiscal Q3 201730800001437749-17-018929
10-Q2017-08-10fiscal Q2 201731890001437749-17-014436
10-Q2017-05-22fiscal Q1 201725510001437749-17-009824
10-K2017-03-10fiscal FY 2016311610001437749-17-004317
10-Q2016-11-10fiscal Q3 201624670001437749-16-041751
10-Q2016-08-11fiscal Q2 201629840001437749-16-037200
10-Q2016-05-13fiscal Q1 201624490001564590-16-019302
10-K2016-03-16fiscal FY 2015271410001564590-16-014881
10-Q2015-11-13fiscal Q3 201523660001564590-15-010727
10-Q2015-08-14fiscal Q2 201523650001564590-15-007410
10-Q2015-05-29fiscal Q1 201523480001564590-15-004751

Inspect the source

Entity
Zevra Therapeutics, Inc. / CIK 0001434647
Captured
2026-09-20T09:02:58.411Z
SEC response SHA-256
e6444155e299482d8e745cbcf52e94d14227a2668e6d953fd1eb25cffef79d18

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001434647.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))